Polymyxins (polymyxin E/colistin and polymyxin B) are considered the last-resort therapy against carbapenem-resistant Enterobacterales; however, the resistance of Enterobacterales to polymyxins is increasing worldwide
No takes yet. Share an insight, caveat, or question.
Dalmolin et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: